Upper respiratory tract weight gain

Other adverse reactions include vaginitis, headache, upper respiratory tract infection, leukorrhea, sinusitis, weight gain, and nausea. 

Low concentration group appeared normal and gained weight. At 1000 gg/L, ocular and nasal discharges. At the high concentration, severe irritation evident plus nonspecific inflammation of brain, heart, lung, liver, and kidney no deaths 81-84% of acrolein retained accumulations greater in upper respiratory tract than lower respiratory tract... 

Adverse reactions occurring in 3% or more of patients include tremor, acne, constipation, diarrhea, nausea, increased serum creatinine, edema, hypercholesterolemia, hyperkalemia, hypokalemia, hyperlipemia, hypophosphatemia, peripheral edema, weight gain, rash, dyspepsia, vomiting, anemia, thrombocytopenia, leukopenia, dyspnea, pharyngitis, upper respiratory tract infection, abdominal pain, asthenia, back/chest pain, fever, headache, pain, arthralgia, urinary tract infection, hypertension. 

At 3 ppm Irritation of the eyes and upper respiratory tract, decreased body weight gain, increased urine specific gravity. 

The most commonly reported adverse events with both pioglitazone and rosiglitazone were upper respiratory tract infection and headache, although other side effects include abnormal liver function, edema, weight gain, and anemia. 

Divalproex sodium extended-release has been evaluated in a 12-month, open extension of a 3-month, double-blind, placebo-controlled, multicenter study in 112 adolescents with migraine [339. The most common symptomatic adverse events were weight gain (15%), nausea (14%), somnolence (12%), upper respiratory tract infection (11%), and sinusitis (8%). Five subjects had serious adverse events, and 15 prematurely withdrew because of an adverse event. Plasma ammonia concentrations were increased in 8% but there were no other clinically significant changes in laboratory values, vital signs, or electrocardiography. 

Reviews A review of quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy reported the most common adverse events in acute trials were somnolence, sedation, dry mouth, weight gain, dizziness, asthenia, pharyngitis and postural hypotension [210 ]. In the maintenance trials, the most common adverse events were somnolence, upper respiratory tract infection, nasopharyngitis and headache. 

---